In particular, a recent study carried out in breast cancer suggested that ERβ activation could inhibit cancer cell proliferation through a mechanism that bring into play a marked reduction of G2/M phase as well as triggering autophagy [14]. Here, ESR2 is linked to breast carcinoma.